Black Rock Inc. Precigen, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Precigen, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,363,128 shares of PGEN stock, worth $14.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,363,128

Previous 11,120,120 6.81%

Holding current value

$14.5 Million

Previous $14.9 Million 0.85%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.21 - $1.75 $915,960 - $1.32 Million	-756,992 Reduced 6.81%	10,363,128 $15 Million
Q4 2023 Feb 13, 2024	BUY	$0.89 - $1.41 $590,837 - $936,045	663,862 Added 6.35%	11,120,120 $14.9 Million
Q3 2023 Nov 13, 2023	BUY	$1.08 - $1.85 $96,783 - $165,785	89,614 Added 0.86%	10,456,258 $14.8 Million
Q2 2023 Aug 11, 2023	BUY	$0.96 - $1.4 $753,369 - $1.1 Million	784,760 Added 8.19%	10,366,644 $11.9 Million
Q1 2023 May 12, 2023	BUY	$0.88 - $2.19 $1.24 Million - $3.09 Million	1,409,360 Added 17.25%	9,581,884 $10.2 Million

Q4 2022 Feb 13, 2023	BUY	$1.27 - $2.26 $427,958 - $761,563	336,975 Added 4.3%	8,172,524 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$1.41 - $2.79 $137,212 - $271,506	97,314 Added 1.26%	7,835,549 $16.6 Million
Q2 2022 Aug 12, 2022	BUY	$1.15 - $2.53 $589,483 - $1.3 Million	512,594 Added 7.09%	7,738,235 $10.4 Million
Q1 2022 May 12, 2022	BUY	$1.91 - $3.98 $88,234 - $183,860	46,196 Added 0.64%	7,225,641 $15.2 Million
Q4 2021 Feb 10, 2022	BUY	$3.53 - $5.5 $25,183 - $39,237	7,134 Added 0.1%	7,179,445 $26.6 Million
Q3 2021 Nov 09, 2021	SELL	$4.99 - $6.55 $117,908 - $154,769	-23,629 Reduced 0.33%	7,172,311 $35.8 Million
Q2 2021 Aug 11, 2021	BUY	$6.24 - $8.22 $44.9 Million - $59.2 Million	7,195,940 New	7,195,940 $46.9 Million

Others Institutions Holding PGEN

# of Institutions

141

Shares Held

145M

Call Options Held

208K

Put Options Held

43.7K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $291M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account